Onion and its anti-cancer effect: what does science say?

Editorial Note

Article originally published in the past and updated according to scientific and divulgative criteria. The purpose is informative: it does not replace medical advice. The statements reported here are based on experimental studies, observational studies, and scientific reviews cited in the bibliography; limitations and contextualizations are discussed in the text.

IN BRIEF

• Compounds present in onions, particularly flavonoids like quercetin, show antioxidant activity and may reduce tumor growth in animal models.
• Population studies indicate associations between higher Allium consumption (onion, garlic) and reduced risk for some cancers, but results are not uniform and do not establish causality.
• Onion extracts with high quercetin content have shown favorable effects on some metabolic risk factors (e.g., cholesterol) in small clinical trials.
• Differences between experimental evidence and human data, doses, forms (food vs. extract), and clinical contexts necessitate a cautious approach to interpretations.

Abstract: what does science say?

Onion (Allium cepa) contains biologically active compounds—particularly flavonoids like quercetin and various sulfur compounds—which in the laboratory show mechanisms consistent with anti-inflammatory, antioxidant, and antiproliferative effects. In animal models, concentrated doses of these extracts reduce tumor growth; in small clinical studies, quercetin-rich extracts have improved some cardiometabolic indicators. Observational studies in populations show inverse associations between allium consumption and some cancers (e.g., stomach, aerodigestive tract), but the data are not uniform: many studies are case-control, the dosage and form of consumption vary, and it cannot be assumed that simple onion consumption equates to a therapeutic effect like chemotherapy. Controlled clinical trials, standardized dosages, and safety evaluations are needed for any therapeutic use.

Experimental evidence and biological mechanisms

In the laboratory and in animals, quercetin—one of the main flavonoids in onion—has shown the ability to slow tumor growth through various biological pathways. Experiments on murine models and cell cultures document reduced proliferation, activation of apoptotic pathways, and alterations in mitochondrial metabolism that can lead to tumor cell death [1]. These effects are supported by reviews that examine molecular mechanisms: modulation of inflammatory signals, antioxidant effect, interaction with cell survival pathways, and possible synergy with chemotherapeutic drugs in experimental contexts [2].

Limitations of experimental results

Preclinical results are not immediately translatable to humans. Differences concern dosages (often much higher than those achievable with diet), route of administration, extract formulation, and the coexistence of other compounds in the food matrix. Furthermore, the response can vary depending on the type of tumor and the metabolic state of the animal. For these reasons, in vivo observations are useful for understanding biological plausibility, but they are not proof of direct clinical efficacy [1][2].

Clinical evidence and human studies

Clinical studies on onion extracts primarily evaluate cardiovascular or metabolic effects rather than oncological therapeutic use. Small controlled trials, with onion peel/extract supplements rich in quercetin, have shown reductions in total and LDL cholesterol in healthy subjects or specific groups studied for short periods [4]. Additionally, peel extract supplements have been studied for possible reductions in blood pressure in subjects with hypertension, with modest effects in selected subgroups [3].

Cautious interpretation of clinical data

These trials tend to be limited in the number of participants, duration, and standardization of formulations. Therefore, the results are interesting from a biological point of view, but do not justify therapeutic recommendations. It is important to distinguish between use as food in the daily diet and the intake of concentrated extracts used in clinical trials.

Observational data: Allium consumption and cancer risk

Epidemiological studies (case-control and meta-analyses) have investigated the relationship between Allium consumption—which includes onions, garlic, leeks, and related vegetables—and the risk of various cancers. Pooled analyses and meta-analyses indicate inverse associations for some cancer sites (e.g., stomach and some aerodigestive tracts), while results for other cancers are conflicting [5][6][8].

Epidemiological interpretation

The observed associations do not establish causality: they may reflect confounding (e.g., other dietary aspects or lifestyles), exposure measurement error, and cultural variability in food preparation and consumption. Some analyses suggest that high Allium consumption may be correlated with reduced risk in certain geographical contexts or for specific cancer subtypes, but the evidence is neither uniform nor sufficient to convert these results into clinical recommendations [5][6][7].

Safety, adverse effects, and comparison with chemotherapy

The narrative "anti-cancer efficacy like chemotherapy but without side effects" requires clarification. It is true that the dietary use of onions is generally safe for the general population; clinical studies on extracts have reported good tolerability at experimental doses. However, the severe adverse effects typical of systemic chemotherapeutics (cytotoxicity, myelosuppression, organ toxicity) are not comparable to those of a food or a low-dose supplement [2][3].

Why the comparison is inappropriate

Chemotherapeutic drugs are designed to have a marked impact on proliferating cells, with a high-risk profile commensurate with their efficacy in systemic oncology. Evidence on onion and extracts shows biological effects but at very different levels and in different contexts; saying that they "work like chemotherapy" is a misleading simplification. Furthermore, the long-term safety of concentrated extracts in cancer patients has not been evaluated with adequate clinical studies [1][2][3].

What it means in practice

For the general public: including onion and other Allium in the diet as part of a vegetable-rich eating pattern can contribute to a favorable nutritional profile thanks to dietary fiber, micronutrients, and bioactive compounds. However, food consumption should not be interpreted as cancer therapy. The possible protective actions observed in epidemiological studies indicate that diet can modulate risk, but they do not replace screening, diagnosis, and oncological therapies based on consolidated clinical evidence.

For those considering supplements: concentrated formulations (onion peel extracts, quercetin) may have effects on some markers (e.g., cholesterol) in short-term studies, but long-term use, interactions with drugs, and efficacy in oncological contexts are not established. Anyone taking anti-cancer drugs or other therapies should consult their doctor before adding supplements to avoid interactions.

Key takeaways

• Onion flavonoids, such as quercetin, have plausible biological mechanisms against tumor growth in the laboratory, but this is not equivalent to proof of clinical efficacy.[1][2]
• Some observational studies suggest inverse associations between Allium consumption and the risk of certain cancers, but the results are neither consistent nor causal.[5][6]
• Onion extracts show benefits on metabolic parameters (e.g., LDL) in small trials but require extensive confirmation and safety evaluations.[4][3]
• There is no solid evidence that onion intake is equivalent to anti-cancer therapy like chemotherapy; the comparison is misleading.

Limitations of evidence

It is crucial to distinguish between types of studies: experimental studies (in vitro, in vivo) are useful for biological plausibility; observational studies (cohorts, case-control, pooled analysis) can indicate associations but are susceptible to confounding; randomized clinical trials offer the highest level of proof for causal effects but so far are few and limited for the oncological use of onion extracts. Many studies differ in dose, form (whole food vs. extract), duration, population, and outcome. Therefore, immediate translations into therapeutic recommendations are not supported by the available evidence [1][2][3][4][5][6][7][8].

Editorial conclusion

Scientific evidence shows that onion compounds, particularly quercetin, have biological properties consistent with potential protective effects against processes related to carcinogenesis. These results are promising from a research perspective but do not replace clinical evidence of oncological efficacy comparable to standard treatments. For the public, the most robust choice remains a rich and varied diet of vegetables (including the Allium family) as part of habits that reduce known risk factors. For therapeutic indications or the use of concentrated extracts, medical consultation and specific clinical studies are necessary. Science progresses by accumulating evidence: biological plausibility is a starting point, not a conclusion.

Final editorial note

This article has been updated to reflect the current state of bibliographic evidence and to clarify limitations and practical implications. The cited research is available in the "SCIENTIFIC RESEARCH" section with verified DOIs to allow direct consultation of the sources.

SCIENTIFIC RESEARCH

1. Singh N, Bhat TK, Singh R. Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis. Sci Rep. (Scientific Reports). https://doi.org/10.1038/srep24049. [1]
2. Shahrajabian MH, Sun W, Cheng Q. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int. https://doi.org/10.1186/s12935-022-02677-w. [2]
3. Brüll V, Burak C, Stoffel-Wagner B, et al. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br J Nutr. 2015;114:1263–1277. https://doi.org/10.1017/S0007114515002950. [3]
4. Kim J, Cha YJ, Lee KH, Park E. Effect of onion peel extract supplementation on the lipid profile and antioxidative status of healthy young women: a randomized, placebo-controlled, double-blind, crossover trial. Nutr Res Pract. 2013;7(5):373–379. https://doi.org/10.4162/nrp.2013.7.5.373. [4]
5. Galeone C, Turati F, Zhang ZF, et al. Relation of allium vegetables intake with head and neck cancers: Evidence from the INHANCE consortium. Mol Nutr Food Res. 2015;59:1641–1650. https://doi.org/10.1002/mnfr.201500042. [5]
6. Turati F, Galeone C, La Vecchia C, et al. Allium vegetable intake and gastric cancer: a case–control study and meta-analysis. Mol Nutr Food Res. 2015;59:171–179. https://doi.org/10.1002/mnfr.201400496. [6]
7. Frontiers in Nutrition. Allium Vegetables, Garlic Supplements, and Risk of Cancer: A Systematic Review and Meta-Analysis. https://doi.org/10.3389/fnut.2021.746944. [7]
8. Guercio V, Turati F, La Vecchia C, et al. Allium vegetables and upper aerodigestive tract cancers: a meta-analysis of observational studies. Mol Nutr Food Res. 2015;59(9): (meta-analysis). https://doi.org/10.1002/mnfr.201500587. [8]